Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
about
When prostate cancer remains undetectable: The dilemmaRisk factors for acute prostatitis after transrectal biopsy of the prostate.CUA guidelines on prostate biopsy methodology.Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare.Personalized prostate cancer screening among men with high risk genetic predisposition- study protocol for a prospective cohort study.Role of information in preparing men for transrectal ultrasound guided prostate biopsy: a qualitative study embedded in the ProtecT trial.Defining the level of evidence for technology adoption in the localized prostate cancer pathwayComplications of initial prostate biopsy in a European randomized screening trialActive surveillance compared with initial treatment for men with low-risk prostate cancer: a decision analysis.Value and Safety of Midazolam Anesthesia during Transrectal Ultrasound-Guided Prostate Biopsy.Prostate biopsy for the interventional radiologistTransperineal in-bore 3-T MR imaging-guided prostate biopsy: a prospective clinical observational study.Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study.Importance of Local Control in Early-Stage Prostate Cancer: Outcomes of Patients With Positive Post-Radiation Therapy Biopsy Results Treated in RTOG 9408.Observation versus initial treatment for men with localized, low-risk prostate cancer: a cost-effectiveness analysis.Dual Processing Model for Medical Decision-Making: An Extension to Diagnostic Testing.Rapid Identification of Rectal Multidrug-resistant Escherichia coli Before Transrectal Prostate Biopsy.A simple decision analytic solution to the comparison of two binary diagnostic tests.Use of patient-specific MRI-based prostate mold for validation of multiparametric MRI in localization of prostate cancer.Can one blood draw replace transrectal ultrasonography-estimated prostate volume to predict prostate cancer risk?Performing nondiagnostic research biopsies in irradiated tissue: a review of scientific, clinical, and ethical considerationsRisk of hospitalization and death following prostate biopsy in Scotland.Febrile infection in post-prostate biopsy: results of a ten-year single-institution study in South Taiwan.The implementation of screening for prostate cancer.Screening and diagnosis of prostate cancer in patients with ileal pouch-anal anastomosis: consensus from an expert panel.Microbiological characteristics of acute prostatitis after transrectal prostate biopsyOptimization of prostate biopsy: review of technique and complications.Short-term prophylaxis with ciprofloxacin in extended 16-core prostate biopsy.Effect on hemostasis of an absorbable hemostatic gelatin sponge after transrectal prostate needle biopsy.Febrile urinary tract infection after prostate biopsy and quinolone resistance.Release of Cell-free MicroRNA Tumor Biomarkers into the Blood Circulation with Pulsed Focused Ultrasound: A Noninvasive, Anatomically Localized, Molecular Liquid Biopsy.Detection rate of prostate cancer on the basis of the vienna nomogram: a singapore study.Does Leaving the Biopsy Needle in Povidone-Iodine Solution Reduce Infective Complications after Biopsy?Clinical, biochemical and pathological features of initial and repeat transrectal ultrasonography prostate biopsy positive patients.Association between pre-biopsy white blood cell count and prostate biopsy - related sepsis.Comparison between ciprofloxacin and trimethoprim-sulfamethoxazole in antibiotic prophylaxis for transrectal prostate biopsy.Patient-reported complications from fiducial marker implantation for prostate image-guided radiotherapy.Complication rates after prostate biopsy according to the number of sampled cores.Complications of transrectal ultrasound-guided 12-core prostate biopsy: a single center experience with 2049 patients.Miliary tuberculosis following transrectal ultrasonography (TRUS)-guided prostate biopsy.
P2860
Q26795515-6108D26A-EBDA-4950-A22C-EFAADEC3936BQ30480950-FF1371A6-56A8-44CC-8DA2-B831810393AAQ30482174-FB1A678B-DD37-49C3-BDB5-7C58E9385FA1Q30573273-3D184E4C-2917-40B7-AACE-02EFC3C4DD34Q30597063-E4703ACD-EDFD-4392-BD26-AB4298684677Q30625083-BEF1E4FE-E176-4C45-9224-BE9503AA2355Q34061419-CAD996B3-3881-4527-9766-F2A3B3256BB4Q34448107-5D8D1FD5-A786-465D-85FB-DE003D78FA1EQ34659767-C3203246-09DD-42DB-A8DD-033B8C212B20Q34726194-BF720E8C-52DF-43DE-9A02-C5087B9500D1Q35019408-D4FD7946-7201-4F3B-9FC0-65828E439AF0Q35100748-8FEEFFC7-E919-4F65-A8CD-149A0DABF85DQ35660802-A4BFAF0A-AC61-42DD-9BDC-C41C934D338DQ35781022-48207437-F99F-43B6-BDE3-9EA280467A66Q35806400-D7D43B07-742F-45C9-8A72-CCBA7E123CC8Q35921388-ACC558B9-9911-45AB-9A0C-D243C9E402AFQ36421317-3FC5A510-0AA0-4CAE-922E-465F987AC4AEQ36492300-4324E30F-40F9-45C4-A3CB-0823B002CF28Q36501542-A18EA326-ABB6-4E01-96C6-680822194873Q36909145-D3E55A91-1203-41F9-8D4F-B0A9338389A2Q36984204-B7247460-F3CF-47FD-87BB-154DA39292E9Q37579726-72F29BB4-F544-4011-9101-D55E054C4AE7Q37585053-7B3C5B67-9A2E-42CD-8DF3-A04CD01F066BQ37777325-8721A4F8-2F70-4E50-85CC-58AB4CD98A21Q37837466-0FEC710F-C01F-42B7-B3F8-E366BDAF8506Q38095435-F3A6C0DE-5B89-4324-9035-A77BE677B2D2Q38203986-A4662456-FE84-446C-9BD7-1DCB571B05BCQ38391440-E4103214-DEF4-42D9-BCCA-81E61F2CA246Q38392227-F370884B-8205-4A52-9965-186A75B27441Q38432866-296DFABB-9CCB-48FA-801F-ABAB29114DC2Q38734553-AE3A1A9E-3A66-4BEC-A2FD-DA39F7F8E6ADQ38780053-F76C9B80-E70C-4FE0-A5D8-5F58D34711EBQ39015906-06E4F6AE-5A45-48C7-A94D-8BB747A72C3BQ39679092-CF400019-4062-4505-B591-24FBFCA0E9DCQ39921860-4C89E788-AB81-47F1-A702-2CA6D150BB95Q40141132-029E8A86-CFF1-4B00-A37F-F6DAF8FA7F46Q40298928-78B1BA36-7425-4DED-9922-3536B829D098Q40300842-EA11078E-1C54-494B-9F1B-E57AB823C167Q40309729-F100C36E-03F0-4950-8CCD-943BC36DEE0BQ40318541-8A584D5F-6115-4F6C-9A61-D5D3E6F89FBB
P2860
Safety and morbidity of first and repeat transrectal ultrasound guided prostate needle biopsies: results of a prospective European prostate cancer detection study.
description
2001 nî lūn-bûn
@nan
2001 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
Safety and morbidity of first ...... ostate cancer detection study.
@ast
Safety and morbidity of first ...... ostate cancer detection study.
@en
Safety and morbidity of first ...... ostate cancer detection study.
@nl
type
label
Safety and morbidity of first ...... ostate cancer detection study.
@ast
Safety and morbidity of first ...... ostate cancer detection study.
@en
Safety and morbidity of first ...... ostate cancer detection study.
@nl
prefLabel
Safety and morbidity of first ...... ostate cancer detection study.
@ast
Safety and morbidity of first ...... ostate cancer detection study.
@en
Safety and morbidity of first ...... ostate cancer detection study.
@nl
P2093
P1476
Safety and morbidity of first ...... ostate cancer detection study.
@en
P2093
Borkowski A
Dobronski P
Marberger M
Schulman C
P304
P356
10.1097/00005392-200109000-00013
P407
P577
2001-09-01T00:00:00Z